Anti-inflammatory effects of peripheral benzodiazepine receptor ligands in two mouse models of inflammation

European Journal of Pharmacology

Volumn 408, Issue 2, 2000, Pages 199-211

  Torres, Sandra R ^a   Fröde, Tânia S ^a   Nardi, Geisson M ^a   Vita, Natalio ^b   Reeb, Rennée ^b   Ferrara, Pascual ^b   Ribeiro do Valle, Rosa M ^a   Farges, Roseli C ^a  

^a FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

^b SANOFI   (France)

Author keywords

Benzodiazepine receptor; Paw oedema; Peripheral; Pleurisy

Indexed keywords

4' CHLORODIAZEPAM; ANTIINFLAMMATORY AGENT; BENZODIAZEPINE RECEPTOR AFFECTING AGENT; BRADYKININ; CARRAGEENAN; HISTAMINE; INTERLEUKIN 13; INTERLEUKIN 6; LIGAND; N SEC BUTYL 1 (2 CHLOROPHENYL) N METHYL 3 ISOQUINOLINECARBOXAMIDE; SUBSTANCE P;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; DISEASE MODEL; DOSE RESPONSE; DRUG EFFECT; DRUG INHIBITION; INFLAMMATION; MALE; MOUSE; NONHUMAN; PAW EDEMA; PLEURISY; PRIORITY JOURNAL;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTILIPEMIC AGENTS; ANTINEOPLASTIC AGENTS; BENZODIAZEPINONES; DISEASE MODELS, ANIMAL; INFLAMMATION; INTERLEUKIN-13; INTERLEUKIN-6; ISOQUINOLINES; MALE; MICE; RECEPTORS, GABA-A;

EID: 0034680754     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(00)00760-3     Document Type: Article

References (86)

1. Production of hybridoma growth factor by human monocytes
2. Nerve growth factor inhibits some acute experimental inflammation
3. An inducible functional peripheral benzodiazepine receptor in mitochondria of steroidogenic granulosa cells
4. Selective inhibition of cyclooxygenase (COX-2) reverses inflammation and expression of COX-2 and interleukin-6 in rat adjuvant arthritis
5. The peripheral-type benzodiazepine receptor. Localization to the mitochondrial outer membrane
6. Accumulation of inflammatory cells in response to intracutaneous platelet activating factor (PLATELET ACTIVATING FACTOR-acether) in man
7. Identification of des-(Gly-Ile)-endozepine as an effector of corticotropin-dependent adrenal steroidogenesis: Stimulation of cholesterol delivery is mediated by the peripheral benzodiazepine receptor
8. Immunomodulatory effect of peripheral benzodiazepine receptor ligands on human mononuclear cells
9. Cyclooxygenase-2 regulates inducible ICAM-1 and VCAM-1 expression in human vascular smooth muscle cells
10. Isolation of an IL-13-dependent subclone of the B9 cell line useful for the estimation of human IL-13 bioactivity
11. Specific benzodiazepine receptors in rat brain characterized by high-affinity (3H)diazepam binding
12. Tumor necrosis factor alpha (TNF-alpha) activates human adenoidal and cutaneous mast cells to histamine secretion
13. Selected cytokines promote the synthesis of platelet-activating factor in vascular endothelial cells: Comparison between tumor necrosis factor alpha and beta and interleukin-1
14. 2 receptor antagonist
15. Peripheral benzodiazepine receptor modulation with phagocyte differentiation
16. Neurokinin-1 receptor agonists are involved in mediating neutrophil accumulation in the inflamed, but not normal, cutaneous microvasculature: An in vivo study using neurokinin-1 receptor knockout mice
17. Substance P selectively activates TNF-alpha mRNA in rat uterine immune cells: A neuroimmune link
18. New concepts on the mechanisms of action of benzodiazepines
19. Histamine induces IL-6 production by human endothelial cells
20. Adenosine modulation of primed human neutrophils
21. Screens for anti-inflammatory drugs
22. Studies on the mediators of the acute inflammatory response induced in rats in different sites by carrageenan and turpentine
23. A comparison of the acute inflammatory response in adrenalectomized and sham-operated rats
24. Identification of a high-affinity peripheral-type benzodiazepine binding site in rat aortic smooth muscle membranes
25. Dexamethasone suppresses gene expression and production of IL-13 by human mast cell line and lung mast cells
26. Modulation of neutrophil oxidative responses to soluble stimuli by platelet-activating factor
27. Autoradiographic localization of 'peripheral' benzodiazepine binding sites in the rat brain and kidney using [3H]RO5-4864
28. Modulation of carrageenan hind paw oedema by substance P
29. A pharmacologic analysis of the action of platelet-activating factor in the induction of hindpaw oedema in the rat
30. Actions of benzodiazepines on the neuroendocrine system
31. Production of interleukin 13 by alveolar macrophages from normal and fibrotic lung
32. Mouse paw oedema. A new model for inflammation?
33. 2 in a murine model of inflammation: Possible role of cyclooxygenase
34. PK11195, a ligand of the mitochondrial benzodiazepine receptor, facilitates the induction of apoptosis and reverses Bcl-2-mediated cytoprotection
35. Compartmentalization of pro-inflammatory cytokines in tuberculous pleurisy
36. Release of platelet activating factor and its involvement in the first phase of carrageenan-induced rat foot oedema
37. Thy-1 induced on rat endothelium regulates vascular permeability at the sites of inflammation
38. Specialized ability of thymic epithelial cells to mediate positive selection does not require expression of the steroidogenic enzyme p450scc
39. Molecular and functional properties of mitochondrial benzodiazepine receptors
40. Platelet-activating factor stimulates interleukin-6 production by human endothelial cells and synergizes with tumor necrosis factor for enhanced production of granulocyte-macrophage colony stimulating factor
41. Regulation of the expression of peripheral benzodiazepine receptors and their endogenous ligands during rat sciatic nerve degeneration and regeneration: A role for PBR in neurosteroidogenesis
42. Peripheral benzodiazepine binding sites in Nb 2 node lymphoma cells: Effects on prolactin-stimulated proliferation and ornithine decarboxylase activity
43. Substance P enhances cytokine-induced vascular cell adhesion molecule-1 (VCAM-1) expression on cultured rheumatoid fibroblast-like synoviocytes
44. Peripheral benzodiazepine binding sites: Effect of PK 11195, 1-(2-chlorophenyl)-N-methyl-N-(1-methylpropyl)-3-isoquinolinecarb oxamide. In vitro studies
45. Dextram and carrageenan evoke different inflammation in rat with respect to composition of infiltrates and effect of indometacin
46. Characterization of peripheral-type benzodiazepine binding sites in brain using [3H]Ro 5-4864
47. IL-6 increases endothelial permeability in vitro
48. Increased peripheral benzodiazepine binding sites in the brain of patients with Huntington's disease
49. Inhibition by dexamethasone of the lipopolysaccharide-induced increase in IL-6 mRNA abundance and IL-6 production in human polymorphonuclear leukocytes
50. Histamine enhanced the TNF-alfa-induced expression of E-selecin and IACM on vascular endothelial cells
51. Bradykinin synergistically stimulates interleukin 6 production in human gingival fibroblasts challenged with interleukin 1 or tumor necrosis factor alpha
52. Enhancement of 5-HT transporter function by tumor necrosis factor alpha but not by interleukin-6
53. Distribution and regulation of cyclooxigenase-2 in carrageenan-induced inflammation
54. Analysis of chemical mediators involved in acute inflammatory reaction with the rat pleurisy model
55. Pharmacological demonstration of inflammatory mediators using experimental inflammatory models: Rat pleurisy induced by carrageenin and phorbol myristate acetate
56. Effects of bradykinin and bradykinin analogues on spleen cells of mice
57. The peripheral-type benzodiazepine receptor is functionally linked to Leydig cell steroidogenesis
58. Pregnenolone biosynthesis in C6 glioma cell mitochondria: Regulation by a diazepam binding inhibitor mitochondrial receptor
59. Peripheral-type benzodiazepine receptors
60. 2 blocks inflammation, hyperalgesia, and interleukin 6 production in vivo
61. Substance P enhances cytokine-induced vascular cell adhesion molecule-1 (VCAM-1) expression on cultured rheumatoid fibroblast-like synoviocytes
62. Traumatic brain injury leads to increased expression of peripheral-type benzodiazepine receptors, neuronal death, and activation of astrocytes and microglia in rat thalamus
63. Lack of IL-10 and IL-13 production by human polymorphonuclear neutrophils
64. Benzodiazepine receptor-mediated chemotaxis of human monocytes
65. Kinetics of peptide-induced release of inflammatory mediators by the urinary bladder
66. Anti-inflammatory effects of theophylline, cromolyn and salbutamol in a murine model of pleurisy
67. 2 receptor antagonist
68. Endogeneous nitric oxide increases prostaglandin biosynthesis in carrageenan rat paw oedema
69. Prenatal diazepam induced persisting depression of cellular immune responses
70. Specific high-affinity binding sites for [3H]Ro 5-4864 in rat brain and kidney
71. The effect of prenatal diazepam exposure on TNF-alpha production by rat splenocytes
72. Benzodiazepine receptors in rat brain
73. Recombinant tumour necrosis factor-alpha and platelet-activating factor synergistically increase intercellular adhesion molecula-1 and E-selectin-dependent neutrophil adherence to endothelium in vitro
74. Anti-inflammatory testing methods: Comparative evaluation of mice and rats
75. Synthesis of corticosterone in the vascular wall
76. Potential role of peripheral benzodiazepine receptors in inflammatory responses
77. Intrinsic prostacyclin contributes to exudation induced by bradykinin or carrageenin: A study on the paw oedema induced in IP-receptor-deficient mice
78. Characterization of the receptor and the mechanisms underlying the inflammatory response induced by des-Arg9-BK in mouse pleurisy
79. Inflammatory determinants of asthma severity: Mediator and cellular changes in bronchoalveolar lavage fluid of patients with severe asthma
80. Benzodiazepines that bind at peripheral sites inhibit cell proliferation
81. 2) production by normal human polymorphonuclear neutrophils by enhancing cyclooxigenase 2 (COX-2) gene expression
82. Altered expression of neutrophil peripheral benzodiazepine receptor in X-linked chronic granulomatous disease
83. In vivo treatment with benzodiazepines inhibits murine phagocyte oxidative metabolism and production of interleukin 1, tumor necrosis factor and interleukin-6
84. Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production
85. Ethical guidelines for investigation of experimental pain in conscious animals
86. Glucocorticoid inhibition of interleukin-1-induced interleukin-6 production by human lung fibroblasts: Evidence for transcriptional and post-transcriptional regulatory mechanisms